Business Description
ASEP Medical Holdings Inc
NAICS : 541710
SIC : 3741
ISIN : CA04368A1057
Share Class Description:
SEPSF: Ordinary SharesCompare
Compare
Traded in other countries / regions
ASEP.CanadaJJ80.GermanySEPSF.USA IPO Date
2022-01-28Description
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -7.3 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.1 | |||||
3-Year FCF Growth Rate | 43.2 | |||||
3-Year Book Growth Rate | -56.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -97.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Cash Ratio | 0.05 | |||||
Days Payable | 87736.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.4 | |||||
Shareholder Yield % | -10.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 97.63 | |||||
Operating Margin % | -661.72 | |||||
Net Margin % | -1353.71 | |||||
EBITDA Margin % | -1893.47 | |||||
FCF Margin % | -302.05 | |||||
OCF Margin % | -302.05 | |||||
ROE % | -115.23 | |||||
ROA % | -38.69 | |||||
ROIC % | -18.92 | |||||
3-Year ROIIC % | -17.83 | |||||
ROC (Joel Greenblatt) % | -49450.7 | |||||
ROCE % | -76.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 5.91 | |||||
PS Ratio | 4.19 | |||||
PB Ratio | 0.7 | |||||
EV-to-EBIT | -0.6 | |||||
EV-to-EBITDA | -0.66 | |||||
EV-to-Revenue | 12.43 | |||||
EV-to-FCF | -4.12 | |||||
Earnings Yield (Greenblatt) % | -166.67 | |||||
FCF Yield % | -49.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEPSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ASEP Medical Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.244 | ||
| EPS (TTM) ($) | -0.305 | ||
| Beta | 0.6817 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.53 | ||
| Volatility % | 97.18 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0109 | ||
| 12-1 Month Momentum % | -97.18 | ||
| 52-Week Range ($) | 0.0109 - 0.387 | ||
| Shares Outstanding (Mil) | 15.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ASEP Medical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ASEP Medical Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-27 | In 125 days | ||
| First quarter earnings results for 2026 | 2026-10-16 | In 83 days | ||
| Second quarter earnings results for 2026 | 2026-10-16 | In 83 days | ||
| General meeting for 2025 | 2026-07-28 | In 3 days | ||
| Annual report for 2025 | 2026-06-30 | 0.01 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-28 | 0.01 (+0.00%) | ||
| Annual report for 2024 | 2025-10-17 | 0.39 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-10-17 | 0.39 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-10-17 | 0.39 (+0.00%) | ||
| 0.1:1 Stock Split | 2025-04-17 | 0.39 (+0.00%) |
Show
Entries
ASEP Medical Holdings Inc Frequently Asked Questions
What is ASEP Medical Holdings Inc(SEPSF)'s stock price today?
The current price of SEPSF is $0.01. The 52 week high of SEPSF is $0.39 and 52 week low is $0.01.
When is next earnings date of ASEP Medical Holdings Inc(SEPSF)?
The next earnings date of ASEP Medical Holdings Inc(SEPSF) is 2026-10-16 Est..
Does ASEP Medical Holdings Inc(SEPSF) pay dividends? If so, how much?
ASEP Medical Holdings Inc(SEPSF) does not pay dividend.
Guru Commentaries on OTCPK:SEPSF
No articles.
Press Release
Articles on ASEP Medical Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers